Bathi operasional sadurunge amortisasi: modernatx.com (MRNA)

Tandha merek Moderna Inc (MRNA)

Moderna, Inc. (MRNA) is transforming its portfolio by scaling oncotherapy and respiratory vaccines. On GURU.Markets, the aggregate EBITDA metric reflects this trend, with the indicator standing at 0.00. However, cash flow volatility reduces business predictability due to a reliance on new regulatory approvals. Meanwhile, the company strictly adheres to ethical governance norms and is implementing ESG standards to reduce industrial waste.

MRNA: Bathi operasional EBITDA Moderna 23.11.2025 - 10.11.2026

Moderna - rincian analitis lan metrik utama (MRNA)

- nilai saham lan prakiraan konsensus rega:
Bagan bursa Moderna Therapeutics|MRNA - Bagan rega target
- indikator kapitalisasi bursa perusahaan:
Kapitalisasi pasar Moderna|MRNA - Nilai Perusahaan
- indikator nilai aset resik miturut neraca:
Nilai Buku Saham Moderna|MRNA - Kapitalisasi Buku|Koefisien Nilai Pasar marang Nilai Buku modernatx.com|MRNA - Total Aset Perusahaan
- rincian struktur utang lan likuiditas bisnis:
Rasio Total Utang marang Ekuitas Moderna, Inc.|MRNA - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka cendhak marang modal Moderna Inc|MRNA - Gunggung utang perusahaan|Utang-utang marang aset resik Moderna|MRNA - Utang jangka dawa perusahaan|Utang jangka cendhak Moderna|Rasio likuiditas darurat modernatx.com
- informasi bathi lan kelipatan valuasi:
MRNA - Bathi resik perusahaan|Prakiraan bathi perusahaan Moderna, Inc.|MRNA - Rasio rega marang bathi|Prakiraan rega marang bathi modernatx.com|MRNA - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Moderna|MRNA - Bathi operasional EBITDA|Bathi saben saham sajrone 12 wulan pungkasan Moderna|MRNA - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan modernatx.com|MRNA - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Moderna, Inc.
Ringkesan analitik perusahaan:MRNA Moderna Therapeutics
Produk seri modernatx.com

To objectively evaluate the issuer, a manager requires an analysis of net cash flow from operating activities. This metric measures operating profit, excluding the impact of taxes and the cost of debt capital. Visualizing EBITDA dynamics helps eliminate accounting noise and confirm earnings stability. For Moderna, Inc. (MRNA), this is critical during a product portfolio transition. The technological superiority of the mRNA platform is currently cushioning margin compression during the vaccine lineup update.

Pesaing Moderna, Inc. (MRNA)

Pendapatan operasional sadurunge ngurangi amortisasi Summit Pharma (SMMT)|PCVX - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|TARS (tarsusrx.com) - Bathi operasional sadurunge amortisasi|CRMD: Bathi operasional EBITDA|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi MCRB (Seres Therapeutics Inc.)|SPRO (Spero) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Scynexis SCYX|Bathi operasional EBITDA ANTX|Bathi operasional sadurunge ngurangi amortisasi polypid.com PYPD|LakeShore Biopharma - Bathi operasional sadurunge ngurangi amortisasi|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi ITRM (Iterum Therapeutics PLC)|BiomX Ltd - Bathi operasional EBITDA|Pendapatan operasional sadurunge ngurangi amortisasi Soligenix, Inc. SNGX|60degreespharma.com (SXTP) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi oragenics.com (OGEN)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi OpGen